Rosetta Genomics Ltd. engages in the provision of therapeutic, diagnostic product development, and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing a diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.
Follow-Up Questions
Rosetta Genomics Ltd (ROSGQ)의 PER은 얼마입니까?
Rosetta Genomics Ltd의 PER은 0입니다
ROSGQ 주식의 가격 성능은 어떻습니까?
ROSGQ의 현재 가격은 $0.0001이며, 전 거래일에 decreased 0% 하였습니다.
Rosetta Genomics Ltd의 주요 사업 주제나 업종은 무엇입니까?
Rosetta Genomics Ltd은 Biotechnology 업종에 속하며, 해당 부문은 Health Care입니다
